ms BETH ROBERTS

H.R. 2356 and S.2363, the Better Wound Care at Home Act

H.R. 2356 and S.2363, the Better Wound Care at Home Act

H.R. 2356 and S.2363, the Better Wound Care at Home Act

Lobbying on general eye health issues and CMS reimbursement issues.

Lobbying on general eye health issues and CMS reimbursement issues.

340B Drug Discount Program - Program Implementation Oversight. Reimbursement for Innovative Products.

340B Drug Discount Program - Program Implementation Oversight. Reimbursement for Innovative Products. Medicare Part D - Benefit redesign legislation and patient access changes. Center for Medicare and Medicaid Innovation - Demonstration program design updates and Congressional oversight.

340B Drug Discount Program - Program Implementation and OversightReimbursement for Innovative Products

340B Drug Discount Program - Program Implementation and OversightReimbursement for Innovative Products

Lobbying on general eye health issues and CMS reimbursement issues.

Lobbying on general eye health issues and CMS reimbursement issues.

340B Drug Discount Program - Program Implementation and OversightReimbursement for Innovative Products

340B Drug Discount Program - Program Implementation and OversightReimbursement for Innovative Products

Lobbying on general eye health issues and CMS reimbursement issues

Issue: 340B Drug Discount ProgramSub-Issue: Program Implementation and Oversight

340B Drug Discount Program, Program Implementation and Oversight

Reimbursement for Innovative Products Value Based Contracting and Communications

340 B Drug Discount Program, Program Implementation and Oversight

340 B Drug Discount Program, Program Implementation and Oversight

Reimbursement for Innovative Products; value-based contracting and communications

340B Drug Discount Program; Program Implementation and Oversight

Reimbursement for Innovative Products; Value-based Contracting and Communications

340B Drug Discount Program; Program Implementation and Oversight

Reimbursement for Innovative Products; Value-based Contracting and Communications

Reimbursement for Innovative Products; Value-based Contracting and Communications

340B Drug Discount Program; Program Implementation & Oversight

Reimbursement for Innovative Products; Affordable Care Act - Repeal & Replace; American Health Care Act

Reimbursement for Innovative Products; CMMI Medicare Part B Proposed Demonstration Project; 340B Drug Pricing Program; Program Implementation & Oversight

Reimbursement for Innovative products; Medicare Part B Physician-Administered Products; CMMI Medicare Part B Proposed Demonstration Project; Value-based Contracting and Communications

Reimbursement for Innovative products; Medicare Part B Physician-Administered Products; CMMI Medicare Part B Proposed Demonstration Project; Value-based Contracting and Communications

Medicare coverage and reimbursement.

Reimbursement for Innovative products; Medicare Part B Physician-Administered Products; CMMI Medicare Part B Proposed Demonstration Project; Value-based Contracting and Communications

Reimbursement for Innovative products; Medicare Part B Physician-Administered Products; CMMI Medicare Part B Proposed Demonstration Project; Value-based Contracting and Communications

Medicare coverage and reimbursement.

Drug and biological coverage, reimbursement, and government price reporting; Reiumbursement for Innovative Therapies; Affordable Care Act Implementation

Average Manufacturer Price Calculations

Medicare coverage and reimbursement.

Assist client with work on H.R. 1018 and S. 1253, Patient Access to Disposable Medical Technology Act of 2015, H.R. 6, 21st Century Cures Act and H.R. 2029, Consolidated Appropriations Act of 2016

Drug and biological coverage, reimbursement, and government price reporting

Medicare coverage and reimbursement.

CMS reimbursement issues.

Monitoring and lobbying on radiation oncology treatment access.

CMS reimbursement issues.

Medicare coverage and reimbursement.

Drug and biological coverage, reimbursement, and government price reporting

Assist client with work on H.R. 1018 and S. 1253, Patient Access to Disposable Medical Technology Act of 2015, and H.R. 6, 21st Century Cures Act

Medicare hospital outpatient prospective payment system.

340B Program and 21st Century Cures issues.

CMS reimbursement issues.

Monitoring and lobbying on radiation oncology treatment access.

Assist client with work on H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015; and H.R. 6, 21st Century Cures Act.

Reimbursement issues regarding anti-infective products.

Assist client with work on H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015.

340B Program and 21st Century Cures issues.

Medicare hospital outpatient prospective payment system.

CMS reimbursement issues.

Monitoring and lobbying on radiation oncology treatment access.

Client is concerned about the impact of a CMS payment rule that packages skin substitutes.

CMS reimbursement issues.

CMS reimbursement issue.

Monitoring and lobbying on radiation oncology treatment access.

Medicare hospital outpatient prospective payment system.

Client is concerned about the impact of a CMS payment rule that packages skin substitutes.

CMS reimbursement issue.

CMS reimbursement issues.

Medicare hospital outpatient prospective payment system.

Monitoring and lobbying on radiation oncology treatment access.

CMS Reimbursement Issues.

CMS Reimbursement Issues.

Client is concerned about the impact of a CMS payment rule that packages skin substitutes.

Monitoring and lobbying on radiation oncology treatment access.

Medicare hospital outpatient prospective payment system.

Monitoring and lobbying on radiation oncology treatment access.

Medicare hospital outpatient prospective payment system.

Medicare hospital outpatient prospective payment system.

Medicare coverage and reimbursement

Medicare hospital outpatient prospective payment system.

Medicare coverage and reimbursement

FDA drug approval

Medicare hospital outpatient prospective payment system.

Medicare coverage and reimbursement of medical devices; Health reform implementation and medical device tax

Medicare coverage and reimbursement of medical devices; Health reform implementation and medical device tax

Medicare hospital outpatient prospective payment system.

Medicare.

Medicare.

Medicare hospital outpatient prospective payment system.

Medicare.

Medicare hospital outpatient prospective payment system.

Medicare.

Medicare hospital outpatient prospective payment system.

Medicare hospital outpatient prospective payment system.

Medicare.

Medicare hospital outpatient prospective payment system.

Medicare

Medicare

Medicare hospital outpatient prospective payment system

Medicare coverage

Medicare

Medicare hospital outpatient prospective payment system

Medicare coverage

Medicare.

Medicare hospital outpatient prospective payment system

Medicare Coverage.

Medicare hospital outpatient prospective payment system.

Medicare.

Health Reform implementation; annual fee on branded prescription pharmaceutical manufacturers.

Medicare coverage and reimbursement of drugs and biological's and the 340B program.

Medicare.

Health Reform implementation; annual fee on branded prescription pharmaceutical manufacturers.

Medicare coverage and reimbursement of drugs and biological's and the 340B program.

Medicare hospital outpatient prospective payment system.